Blinding problems impair integrity of psychedelics trials: Study

When conducting randomized controlled trials, the study drug is pitted against a placebo. The problem with psychedelics trials is that subjects always know when they have been given a psychedelic. The only “placebo” for a psychedelic is another drug with similar properties, because psychedelics have such obvious effects.

Authors

Publication Details

Journal
Alcoholism & Drug Abuse Weekly
Published
2026-04-17
DOI
https://doi.org/10.1002/adaw.34884
Primary Topic
Psychedelics and Drug Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Blinding problems impair integrity of psychedelics trials: Study

Alison Knopf
Alcoholism & Drug Abuse Weekly
Psychedelics and Drug Studies
article

Blinding problems impair integrity of psychedelics trials: Study

Alison Knopf
article en

Abstract

When conducting randomized controlled trials, the study drug is pitted against a placebo. The problem with psychedelics trials is that subjects always know when they have been given a psychedelic. The only “placebo” for a psychedelic is another drug with similar properties, because psychedelics have such obvious effects.

Alcoholism & Drug Abuse WeeklyVol. 38(16)
Good health and well-being
Openalex Percentile: Top 5%
Psychedelics and Drug Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Blinding problems impair integrity of psychedelics trials: Study — Alison Knopf · Alcoholism & Drug Abuse Weekly (2026) | TGRS Research Map | TGRS